Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Allan T Bombard, MD
Sequenom, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre Hospitalier Universitaire de Nantes
Nantes, France
- Hopital Cochin Port Royal
Paris, France
- Hopital Robert Debre
Paris, France
- Hopital Paule de Viguier - Chu Toulouse
Toulouse, France
- Centre Hospitalier Regional Et Universitaire - Hopital Bretonneau
Tours, France
- University of South Alabama
Mobile, Alabama, United States
- Grossmont Center for Clinical Research
La Mesa, California, United States
- Igo
San Diego, California, United States
- Poway Womens Care
San Diego, California, United States
- San Diego Perinatal Center
San Diego, California, United States
- Women'S Healthcare at Frost Street
San Diego, California, United States
- Visions Clinical Research
Boynton Beach, Florida, United States
- South Florida Perinatal Medicine
Miami, Florida, United States
- University of Miami
Miami, Florida, United States
- Global Ob/gyn Centers
Pembroke Pines, Florida, United States
- Discovery Clinical Research
Sunrise, Florida, United States
- Sheridan Clinical Research
Sunrise, Florida, United States
- Fetal Diagnostic Institution of the Pacific
Honolulu, Hawaii, United States
- Women'S Clinic
Boise, Idaho, United States
- Reproductive Genetics Institute
Chicago, Illinois, United States
- Spectrum Health - Maternal Fetal Medicine
Grand Rapids, Michigan, United States
- William Beaumont Hospital
Royal Oak, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- St Louis University
St Louis, Missouri, United States
- Methodist Hospital
Omaha, Nebraska, United States
- Cooper University Hospital
Camden, New Jersey, United States
- Lyndhurst Gynecologic Associates
Winston-Salem, North Carolina, United States
- Complete Healthcare for Women
Columbus, Ohio, United States
- Clinical Trials of America
Eugene, Oregon, United States
- Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Kingsport Perinatology
Kingsport, Tennessee, United States
- Perinatal Research Center
Nashville, Tennessee, United States
- Tenessee Maternal Fetal Medicine
Nashville, Tennessee, United States
- Houston Perinatal Associates
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2009
- Primary completion
- 30 Sept 2011
- Completion
- 31 Dec 2011
- Last update posted
- 17 Feb 2012
- Registered enrollment
- 2,502
- Registry id
- NCT00971334
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.